(Q51068251)

28 March 2018

editorial

0 references

title

The messenger's great message for vaccination. (English)

1 reference

28 March 2018

author name string

Steve Pascolo

series ordinal

1

1 reference

28 March 2018

publication date

1 February 2015

1 reference

28 March 2018

Expert Review of Vaccines

published in

1 reference

28 March 2018

volume

14

1 reference

28 March 2018

issue

2

1 reference

28 March 2018

page(s)

153-156

1 reference

28 March 2018

mRNA-based therapeutics--developing a new class of drugs

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Self-replicating Semliki Forest virus RNA as recombinant vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Vaccination with messenger RNA (mRNA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

mRNA-based vaccines synergize with radiation therapy to eradicate established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Intralymphatic injections as a new administration route for allergen-specific immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

mRNA vaccination as a safe approach for specific protection from type I allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1000871

10.1586/14760584.2015.1000871

21 January 2018

Identifiers

DOI

1 reference

28 March 2018

1 reference

28 March 2018